Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Using steroids can increase the risk of heart problems.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Testosterone helps human pancreatic cells increase insulin release.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Counterfeit drugs for bodybuilders often contain incorrect or contaminated ingredients and look like real products.

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Letrozole may help prevent seizures by reducing certain hormone levels.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

PLD is an effective and safer alternative for treating breast cancer.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.